Histological and clinical evaluation of recombinant human platelet-derived growth factor combined with beta tricalcium phosphate for the treatment of human Class III furcation defects.

Four patients with chronic advanced periodontitis participated in this study. At least one mandibular first molar had to have a hopeless periodontal and prosthetic prognosis. Clinical measurements were made, and the furcation defects were surgically exposed.